Cargando…

Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions

Detalles Bibliográficos
Autor principal:	Lauschke, Volker M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598308/ https://www.ncbi.nlm.nih.gov/pubmed/37886211 http://dx.doi.org/10.21037/hbsn-23-376

Ejemplares similares

Non-alcoholic fatty liver disease: an update on diagnosis
por: DUMITRASCU, DAN L., et al.
Publicado: (2018)

Long-term BP variability: open questions in clinical practice
por: Del Pinto, Rita, et al.
Publicado: (2020)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
por: Oh, Hyunwoo, et al.
Publicado: (2016)

Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
por: Ullah, Rahim, et al.
Publicado: (2019)

Pediatric non alcoholic fatty liver disease: more on novel treatment targets
por: Vajro, Pietro, et al.
Publicado: (2013)

Recently published papers: Changing bandwagons, innovations and questioning dogma
por: Ball, Jonathan
Publicado: (2009)

New guidance to seekers of autism biomarkers: an update from studies of identical twins
por: Constantino, John N.
Publicado: (2021)

Capturing what matters: updating NICE methods guidance on measuring and valuing health
por: Dawoud, Dalia, et al.
Publicado: (2022)

Metaknowledge Enhanced Open Domain Question Answering with Wiki Documents
por: Liu, Shukan, et al.
Publicado: (2021)

Are the polyol pathway and hyperuricemia partners in the development of non‐alcoholic fatty liver disease in diabetes?
por: Hotta, Nigishi, et al.
Publicado: (2020)

Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics
por: Best, Jan, et al.
Publicado: (2021)

SARS-CoV-2 and human reproduction: An open question
por: Entezami, Frida, et al.
Publicado: (2020)

Commentary: Aortic valve replacement in young adults: An open question
por: da Costa, Francisco Diniz Affonso
Publicado: (2021)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

NICE medical technologies guidance: aims for clinical practice
por: Campbell, Bruce
Publicado: (2013)

Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
por: Javed, Afzal, et al.
Publicado: (2019)

Education and Training in Clinical Neuropsychology: Recent Developments and Documents From the Clinical Neuropsychology Synarchy
por: Smith, Glenn
Publicado: (2018)

How Covid-19 opened up questions of sociomateriality in healthcare education
por: Cleland, Jennifer, et al.
Publicado: (2020)

Unanswered Questions in Clinical Practice
por: Lynch, Tim, et al.
Publicado: (2023)

Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results
por: Zhou, Yitian, et al.
Publicado: (2022)

Recent advances in non-alcoholic fatty liver disease
por: Polewiczowska, Beata, et al.
Publicado: (2018)

Detection of a gammaretrovirus, XMRV, in the human population: Open questions and implications for xenotransplantation
por: Denner, Joachim
Publicado: (2010)

A commentary on the discrepancy between blood and tumour BRCA testing: An open question
por: De Paolis, Elisa, et al.
Publicado: (2022)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?
por: Sanyal, Arun J.
Publicado: (2018)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Canadian Stroke Best Practice Guidance During the COVID-19 Pandemic
por: Smith, Eric E., et al.
Publicado: (2020)

Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

Non-alcoholic Fatty Liver Disease: A Clinical Update
por: Pappachan, Joseph M, et al.
Publicado: (2017)

Harmaline-Induced Tremor in Mice: Videotape Documentation and Open Questions About the Model
por: Cheng, Melody M., et al.
Publicado: (2013)

Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure
por: Goñi, Francisco J., et al.
Publicado: (2022)

Universal Alcohol/Drug Screening in Prenatal Care: A Strategy for Reducing Racial Disparities? Questioning the Assumptions
por: Roberts, Sarah C. M., et al.
Publicado: (2010)

AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons
por: Pinazo-Bandera, Jose María, et al.
Publicado: (2023)

Alcohol related work place injuries: More Questions than Answers!
por: Mountain, David
Publicado: (2015)

Is the practice of colorectal cancer screening questionable after the NordICC trial was published?
por: Wong, Martin C. S., et al.
Publicado: (2023)

The unintended consequences of COVID-19 mitigation measures matter: practical guidance for investigating them
por: Turcotte-Tremblay, Anne-Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dlqi2p401gfi8tmv6i79allf0o